Compare VanEck Australian Floating Rate ETF (FLOT) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Australian Floating Rate ETF vs Heron Therapeutics Inc — how do they compare? VanEck Australian Floating Rate ETF trades at $50.93, while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: VanEck Australian Floating Rate ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| FLOT | HRTX | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $51.09 | $1.49 |
52-Week Low | $50.72 | $0.32 |
Market Cap | — | $61.47M |
Enterprise Value | — | $168.21M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Australian Floating Rate ETF
FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.
Read more on FLOT →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
